tolnaftate 0.01 MG/MG
RxNorm concept 340019, clinical drug component (scdc).
- RxCUI
- 340019
- Term type
- Clinical drug component (SCDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/340019 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- tolnaftate 0.01 MG/MG Topical Ointment (SCD, constitutes)
- tolnaftate 0.01 MG/MG Topical Powder [Tinactin] (SBD, constitutes)
- tolnaftate 0.01 MG/MG Topical Gel (SCD, constitutes)
- tolnaftate 0.01 MG/MG Topical Powder (SCD, constitutes)
- tolnaftate 0.01 MG/MG Topical Powder [Lamisil Defense] (SBD, constitutes)
- tolnaftate 0.01 MG/MG Powder Spray (SCD, constitutes)
- tolnaftate 0.01 MG/MG Powder Spray [Tinactin] (SBD, constitutes)
- tolnaftate 0.01 MG/MG Powder Spray [Lamisil Defense] (SBD, constitutes)
- tolnaftate (IN, has ingredient)
- tolnaftate 0.01 MG/MG [Tinactin] (SBDC, has tradename)
- tolnaftate 0.01 MG/MG [Lamisil Defense] (SBDC, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 340019 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/340019 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 340019. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.